Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated donor stem cell transplantation for high-risk hematologic cancers. The study status is terminated and results were posted on 2013-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2013-12-18